Cofactor Genomics
Eric Duncavage, MD is currently working as a Professor of Pathology and Immunology at Washington University in St. Louis. Eric also serves as the Medical Director at Geneoscopy and Cofactor Genomics. Prior to their current roles, Eric was an Instructor at the University of Utah and a Pre-doctoral fellow at Saint Jude Children's Research Hospital. Dr. Duncavage holds a BA in Physics and Chemistry from Vanderbilt University, an MD from the University of Tennessee-Health Science Center College of Medicine, and has completed fellowships in Hematopathology and Molecular Genetic Pathology.
This person is not in any offices
Cofactor Genomics
Cofactor Genomics is bridging the precision medicine gap by building diagnostic tools to match the right patient to the right treatment at the right time. Predicting patient response currently relies on isolated, single-analyte biomarkers that have failed to deliver accurate therapy response predictions, resulting in unnecessary healthcare costs, and most harmfully, negative outcomes for patients. Cofactor’s products use Predictive Immune Modeling, which leverages RNA data and machine learning to combine biological signals, creating multidimensional biomarkers to deliver on the promise of precision medicine. Cofactor Genomics offers its full-service molecular, informatic, and database tools to make drug discovery, clinical trials and therapy selection more successful.